Stocktoria
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI
IT · Borsa Italiana · XMIL · stock · Healthcare · website
Recordati Industria Chimica e Farmaceutica S.p.A. financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | €2.6B | €2.3B | €2.1B | €1.9B |
| Gross profit | €1.8B | €1.6B | €1.4B | €1.3B |
| R&D expense | €341.0M | €286.0M | €255.7M | €220.1M |
| SG&A expense | €727.0M | €654.4M | €601.1M | €572.2M |
| Operating income | €719.7M | €659.9M | €565.8M | €494.2M |
| Interest expense | €99.3M | €81.5M | €74.9M | €32.2M |
| Income tax | €137.7M | €130.7M | €101.8M | €89.1M |
| Net income | €443.6M | €416.5M | €389.2M | €312.3M |
| EPS (diluted) | €2.12 | €1.99 | €1.86 | €1.49 |
| Operating cash flow | €596.9M | €569.9M | €485.3M | €461.7M |
| Free cash flow | €511.8M | -€281.2M | €102.1M | €365.4M |
| Cash & equivalents | €428.8M | €322.4M | €221.8M | €284.7M |
| Inventory | €539.8M | €506.4M | €404.8M | €424.1M |
| Goodwill | €795.7M | €797.1M | €778.4M | €780.1M |
| Total assets | €5.3B | €5.1B | €4.2B | €4.0B |
| Total debt | €2.5B | €2.5B | €1.8B | €1.7B |
| Total liabilities | €3.3B | €3.3B | €2.5B | €2.5B |
| Shareholders' equity | €1.9B | €1.9B | €1.7B | €1.5B |
| Share buybacks | €157.1M | €119.0M | €22.7M | €52.3M |
Growth · year-over-year · Revenue CAGR 12.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +11.8% | +12.4% | +12.4% | — |
| Net income growth | +6.5% | +7.0% | +24.6% | — |
| EPS growth | +6.5% | +7.0% | +24.6% | — |
| Free cash flow growth | — | -375.6% | -72.1% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · IT · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.